Carbomer homopolymer type C

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Carbomer homopolymer type C
Accession Number
DB14091
Type
Small Molecule
Groups
Experimental, Investigational
Description

Carbomer homopolymer type C is a high molecular polyanionic substance tested for antiulcerogenic activity.

Synonyms
  • Acrypol 940
  • Carbomer 934P
  • Carbomer 980
  • Carbomer homopolymer type C (allyl pentaerythritol crosslinked)
  • Carbomer-940
  • Carbomer-980
  • Carbopol 980 polymer
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
RRB PakCarbomer homopolymer type C (1 g/1g) + Betamethasone dipropionate (0.5 mg/1g)KitTopicalAlvix Laboratories2015-12-12Not applicableUs
Categories
UNII
4Q93RCW27E
CAS number
57916-92-4

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedOtherAcute Rhinitis1
1, 2RecruitingTreatmentPruritus1
2CompletedTreatmentAcute Rhinitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
KitTopical
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on June 18, 2018 10:49 / Updated on May 01, 2019 11:57